Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $234.49 million. The enterprise value is -$189.50 million.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 85.58 million shares outstanding. The number of shares has increased by 1.25% in one year.
| Current Share Class | 85.58M |
| Shares Outstanding | 85.58M |
| Shares Change (YoY) | +1.25% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 13.51% |
| Owned by Institutions (%) | 55.17% |
| Float | 66.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.94, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.94 |
| Quick Ratio | 19.56 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.47% and return on invested capital (ROIC) is -13.80%.
| Return on Equity (ROE) | -30.47% |
| Return on Assets (ROA) | -12.77% |
| Return on Invested Capital (ROIC) | -13.80% |
| Return on Capital Employed (ROCE) | -24.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.49M |
| Employee Count | 56 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVIR has paid $897,000 in taxes.
| Income Tax | 897,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.01% in the last 52 weeks. The beta is 0.17, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -26.01% |
| 50-Day Moving Average | 2.92 |
| 200-Day Moving Average | 3.25 |
| Relative Strength Index (RSI) | 46.47 |
| Average Volume (20 Days) | 477,278 |
Short Selling Information
The latest short interest is 3.05 million, so 3.56% of the outstanding shares have been sold short.
| Short Interest | 3.05M |
| Short Previous Month | 2.97M |
| Short % of Shares Out | 3.56% |
| Short % of Float | 4.59% |
| Short Ratio (days to cover) | 7.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | -80.83M |
| Operating Income | -101.45M |
| Pretax Income | -174.95M |
| Net Income | -139.49M |
| EBITDA | -101.04M |
| EBIT | -101.45M |
| Earnings Per Share (EPS) | -$1.65 |
Full Income StatementBalance Sheet
The company has $425.44 million in cash and $1.45 million in debt, giving a net cash position of $423.99 million or $4.95 per share.
| Cash & Cash Equivalents | 425.44M |
| Total Debt | 1.45M |
| Net Cash | 423.99M |
| Net Cash Per Share | $4.95 |
| Equity (Book Value) | 411.08M |
| Book Value Per Share | 4.80 |
| Working Capital | 411.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | -126.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | -126.20M |
| FCF Per Share | -$1.47 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |